Introduction Atrial fibrillation (AF) is an abnormal heart rhythm characterized by an irregular
beating of the atria and is associated with an increased risk of heart failure, dementia, and …

Background Using human humoral metabolomic profiling, we can discover the diagnostic
biomarkers and pathogenesis of disease. The specific characterization of atrial fibrillation …

Background The exact mechanism of atrial fibrillation (AF)-induced heart failure (HF)
remains unclear. Proteomics and metabolomics were integrated to in this study, as to …

Atrial fibrillation (AF) is one of the most common types of arrhythmias and often leads to
clinical complications. The objectives of this study were to offer insights into the metabolites …

Atrial fibrillation (AF) is an abnormal heart rhythm related to an increased risk of heart failure,
dementia, and stroke. The distinction between valvular and non-valvular AF remains a …

Background Mitral valve disease (MVD)-associated atrial fibrillation (AF) is one of the most
common arrhythmias with an increased risk of thromboembolic events. This study aimed to …

Atrial fibrillation (AF) is a common cardiac arrhythmia leading to many adverse outcomes
and increased mortality. Yet the molecular mechanisms underlying AF remain largely …

Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice and is
associated with morbidity and mortality. Over the past 2 decades, there have been major …

Atrial fibrillation (AF) and cardiometabolic syndrome (CMS) have been linked to
inflammation and fibrosis. However, it is still unknown which inflammatory cytokines …

Objective. This study is aimed at understanding the molecular mechanisms and exploring
potential therapeutic targets for atrial fibrillation (AF) by multiomics analysis. Methods …